Community Awareness Resources and Education - Project 1 (CARE)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01172561 |
Recruitment Status :
Completed
First Posted : July 29, 2010
Last Update Posted : March 23, 2023
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Cervical Cancer | Behavioral: Lay Health Advisor Education Intervention Behavioral: Usual Care Group | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 280 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | Triple (Care Provider, Investigator, Outcomes Assessor) |
Primary Purpose: | Screening |
Official Title: | Reducing Cervical Cancer in Appalachia |
Actual Study Start Date : | March 1, 2005 |
Actual Primary Completion Date : | May 31, 2008 |
Actual Study Completion Date : | March 31, 2009 |

Arm | Intervention/treatment |
---|---|
Active Comparator: Usual Care Group
All women over age 18 encouraged to obtain Pap smears appropriate for their risk profile, the comparison arm included a low-literacy brochure to encourage women to receive screening. The brochure was designed to answer basic questions about Pap smears and provide instructions on how to obtain a Pap smear.
|
Behavioral: Usual Care Group
All women over age 18 encouraged to obtain Pap smears appropriate for their risk profile, the comparison arm included a low-literacy brochure to encourage women to receive screening. The brochure was designed to answer basic questions about Pap smears and provide instructions on how to obtain a Pap smear. |
Experimental: Lay Health Advisor Intervention
The Lay Health Advisor education intervention - The intervention consisted of an intensive, reinforced, one on one, interactive ed. program (an initial meeting, then 2 calls and a series of 4 postcards mailed at regular intervals and a 2nd visit. Woman were enrolled for about 12 to 14 months.
|
Behavioral: Lay Health Advisor Education Intervention
The individualized health education intervention consisted of an intensive, reinforced, face to face, interactive educational program. The program included an initial meeting of 45 60 minutes, followed by two telephone calls and reinforcement by a series of four postcards mailed at regular intervals and a second visit. Each woman will be enrolled in the intervention program for approximately 12 to 14 months. |
- Receipt of Cervical Cancer screening via Pap Test [ Time Frame: past 12-14 months (yes/no). ]the primary outcome of interest for Project 1 intervention will be a dichotomous variable, Pap smear in the past 12-14 months (yes/no). Initially, We will assess the univariate difference between treatment groups (lay health advisor vs. brochure and physician letter) in the proportion of women who received a Pap smear during the past 12 months using design-based logistic regression.

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | Female |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
-
women age 18 and older
- who have visited participating clinics during the last two years and
- who consider themselves to be a current patient of that clinic
Exclusion Criteria:
- Not a resident of the selected Ohio Appalachia county
- Under the age of 18

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01172561
United States, Ohio | |
The Ohio State University Comprehensive Cancer Center | |
Columbus, Ohio, United States, 43201 |
Principal Investigator: | Electra D Paskett, Ph.D. | The Ohio State University Comprehensive Cancer Center |
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: | Electra Paskett, Professor, Ohio State University Comprehensive Cancer Center |
ClinicalTrials.gov Identifier: | NCT01172561 |
Other Study ID Numbers: |
OSU-0488 P50CA105632 ( U.S. NIH Grant/Contract ) NCI-2012-00212 ( Registry Identifier: Clinical Trials Reporting Program (CTRP) ) |
First Posted: | July 29, 2010 Key Record Dates |
Last Update Posted: | March 23, 2023 |
Last Verified: | March 2023 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | No |
Uterine Cervical Neoplasms Uterine Neoplasms Genital Neoplasms, Female Urogenital Neoplasms Neoplasms by Site Neoplasms Uterine Cervical Diseases |
Uterine Diseases Genital Diseases, Female Female Urogenital Diseases Female Urogenital Diseases and Pregnancy Complications Urogenital Diseases Genital Diseases |